Building Health Industries in Emerging Economies: The Case of Santelys Pharmaceutical in Cambodia

HRMARS - Cambodia’s pharmaceutical sector, once limited by state ownership and underdeveloped infrastructure, is now witnessing gradual modernization in response to rising healthcare demands and regional integration. This case study examines the transformation of Santelys Pharmaceutical Co., Ltd., formerly Cambodia Pharmaceutical Enterprise, the nation’s first pharmaceutical manufacturer, established through Chinese government aid. Following Cambodia’s broader economic liberalization, the enterprise underwent privatization and was restructured in 2019 as Santelys, a certified GMP manufacturing facility built to EU PIC/S standards. Drawing on qualitative interview and documentary analysis, the study investigates how the company navigated institutional transition, regulatory adaptation, and quality certification. Key themes include strategic leadership, international collaboration, and mission-driven value creation. The case provides critical insights into pharmaceutical entrepreneurship in resource-constrained contexts and contributes to discourse on industrial upgrading, privatization, and innovation-led growth in emerging health systems.